Literature DB >> 34656369

Pregnancy and CKD: Advances in Care and the Legacy of Dr Susan Hou.

Andrea L Oliverio1, Kate Bramham2, Michelle A Hladunewich3.   

Abstract

Dr Susan Hou began her illustrious nephrology career at a time when pregnancy in women with chronic kidney disease (CKD) was hazardous and actively discouraged. Her pioneering research in women's health provided much of the early outcome data that shaped our current understanding of CKD and pregnancy. Although many uncertainties regarding optimal management of this vulnerable patient group remain, recent decades have witnessed important advances and renewed interest in improving care for pregnant women with CKD. Many nephrologists have been inspired by Dr Hou's lifetime of work and are grateful for her generous collaborations. In this In Practice Review, we honor her legacy by providing an update of current literature and clinical management guidance in the context of a clinical case vignette that challenges us to consider the many complex aspects to the counseling and care of women with CKD who desire a pregnancy.
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease (CKD); family planning; fertility; fetal outcomes; kidney failure; obstetrics; preconception counseling; pregnancy; reproductive health; review; sexual dysfunction

Mesh:

Year:  2021        PMID: 34656369     DOI: 10.1053/j.ajkd.2021.07.016

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   11.072


  2 in total

1.  Effect of New Nursing Team Management Mode on Self-Efficacy, Compliance, and Quality of Life of Patients with Chronic Kidney Disease and Its Chain Mediating Effect.

Authors:  Jie Zheng; YueJuan Jing; AoHan Guo; ShuYan Wu; Rong Liu; LinJun Zhai
Journal:  Contrast Media Mol Imaging       Date:  2022-07-05       Impact factor: 3.009

2.  Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway.

Authors:  Vincent Dupont; Anders H Berg; Michifumi Yamashita; Chengqun Huang; Ambart E Covarrubias; Shafat Ali; Aleksandr Stotland; Jennifer E Van Eyk; Belinda Jim; Ravi Thadhani; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.